Repro Med Ebitda Over Time
| KRMD Stock | USD 3.98 0.06 1.49% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Repro Med Performance and Repro Med Correlation. Repro |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repro Med. If investors know Repro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repro Med listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Earnings Share (0.26) | Revenue Per Share 0.674 | Quarterly Revenue Growth 0.215 | Return On Assets (0.14) |
The market value of Repro Med Systems is measured differently than its book value, which is the value of Repro that is recorded on the company's balance sheet. Investors also form their own opinion of Repro Med's value that differs from its market value or its book value, called intrinsic value, which is Repro Med's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repro Med's market value can be influenced by many factors that don't directly affect Repro Med's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repro Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repro Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Ebitda Analysis
Compare Repro Med Systems and related stocks such as Precision Optics,, InfuSystems Holdings, and Utah Medical Products Ebitda Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POCI | 300 K | (1.3 M) | (1.2 M) | (1.2 M) | (1.3 M) | (1.1 M) | (970.3 K) | (321.4 K) | (445.9 K) | (1.3 M) | 50.2 K | (526.6 K) | (427.8 K) | (2.5 M) | (2.4 M) |
| INFU | (24.5 K) | 10.3 M | 10.3 M | 14.2 M | 15.5 M | 17.1 M | 11.7 M | 9.6 M | 11.7 M | 15.8 M | 22.8 M | 17.2 M | 15.1 M | 16.5 M | 11.3 M |
| UTMD | 1.1 M | 14.6 M | 15.2 M | 18 M | 25 M | 24.2 M | 23.7 M | 21.8 M | (18.7 M) | 17.6 M | 20.9 M | 26.2 M | 26.9 M | 24.8 M | 14.4 M |
| MLSS | (2.1 M) | (991.5 K) | (596.2 K) | 268.2 K | (1.6 M) | (3 M) | (6.4 M) | (4.7 M) | (4 M) | (106.9 K) | (7.4 M) | (7.3 M) | (8.7 M) | (7 M) | (6.6 M) |
| MMSI | (300 K) | 39.2 M | 30.7 M | 31.9 M | 40.9 M | 38.5 M | 34.7 M | 45.2 M | 60.5 M | 38.6 M | 102.7 M | 153.5 M | 181.2 M | 231.4 M | 243 M |
| ATRC | (3.1 M) | (2.8 M) | (5.3 M) | (8.9 M) | (11.6 M) | (20.4 M) | (21.8 M) | (15.9 M) | (8.4 M) | (23.8 M) | (34.7 M) | (36.9 M) | (31 M) | (8.1 M) | (8.5 M) |
| PDEX | (400 K) | (718 K) | (1.3 M) | (275 K) | (318 K) | 1.4 M | 3.4 M | 4.2 M | 5.7 M | 8.7 M | 8.1 M | 6 M | 6.6 M | 8.3 M | 8.7 M |
| LMAT | (282 K) | 7.2 M | 3.7 M | 7.3 M | 7.8 M | 10.8 M | 19.9 M | 25.2 M | 13.3 M | 21.2 M | 36.9 M | 46 M | 36.9 M | 49 M | 51.4 M |
Repro Med Systems and related stocks such as Precision Optics,, InfuSystems Holdings, and Utah Medical Products Ebitda description
My Equities
My Current Equities and Potential Positions
| Repro Med Systems | KRMD |
Specialization | Health Care, Health Care Equipment & Services |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.98
Check out Repro Med Performance and Repro Med Correlation. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Repro Med technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.